- 2014
-
What's on? - 17.07.2014
Chikungunya virus epidemic
The chikungunya virus is an infectious arboviral disease from the family Togaviridae. It comes from tropical regions and is transmitted by Aedes mosquitos. The virus is contracted by the mosquito when it bites an infected individual. It then becomes a carrier and can transmit the disease by biting a healthy person. There is no curative […]
-
Press releases - 17.07.2014
What are the risks of post-traumatic stress disorder after an accident?
The team of Emmanuel Lagarde, research director at Inserm’s Research Centre for Epidemiology and Biostatistics (Inserm/University of Bordeaux) has studied the subsequent development of 1,300 people who were admitted to A&R between 2007 and 2009 for trauma.
-
Press releases - 11.07.2014
100,000 women with breast implants monitored for 10 years
At the request of the Agence Nationale de Sécurité du Médicament et des produits de santé (ANSM) [French National Agency of Medicine and Health Products Safety], a group of researchers managed by Florent de Vathaire in Inserm Unit 1018 Centre for epidemiology and population health research is launching a study entitled LUCIE.
-
Press releases - 11.07.2014
Ultrasound tracks odor representation in the brain
A new ultrasound imaging technique has provided the first ever in vivo visualization of activity in the piriform cortex of rats during odor perception. This deep-seated brain structure plays an important role in olfaction, and was inaccessible to functional imaging until now. This work also sheds new light on the still poorly known functioning of the olfactory system, and notably how information is processed in the brain.
-
News in brief - 04.07.2014
L-Dopa treatment alleviates sleep disturbances associated with Parkinson’s disease
Patients suffering from Parkinson’s disease complain of severe sleep disturbances such as inability to fall asleep or, in contrast, periods of drowsiness during the day. While dopaminergic treatment dramatically improves the disease’s motor symptoms (calming tremors, for instance), its effects on sleep continued to be challenged, suggesting that the alteration of other (non-dopaminergic) neurons might […]
-
Press releases - 04.07.2014
Laser bioprinting in Bordeaux : an innovative approach
One of the goals of the laboratory is to develop laser and microfabrication technologies with the aim of printing tissues in vitro and in vivo. The researchers in the laboratory were pioneers in Europe, developing laser-assisted bioprinting from 2005. This Inserm/University of Bordeaux joint research unit is one of a very few worldwide to use this process. The objective of Fabien Guillemot’s team is therefore not only to position cells in 3D, but to define and model the self-assembly dynamic of the printed cells.
-
News in brief - 02.07.2014
New risk factors for alcohol abuse in adolescents brought to light
An international team involving researchers from INSERM, CEA and APHP in France have successfully modelled the risk factors for alcohol abuse during adolescence. The results of the study were published on Nature Magazine’s website on 2 July. In France, alcohol consumption most often begins in adolescence. Today, 80% of 17-year-olds admit to having consumed alcohol […]
-
Press releases - 30.06.2014
Alzheimer’s disease: simplified diagnosis, with more reliable criteria
How many patients receive an incorrect diagnosis of Alzheimer’s disease? The answer is a surprisingly high number: over a third! To reduce the number of errors, the diagnostic criteria must be the most reliable possible, especially at the very early stages of the disease. For the last decade, an international team of neurologists, coordinated by Bruno Dubois (Inserm/Pierre and Marie Curie University/AP-HP Joint Research Unit 975) has been working towards this. In the June issue of The Lancet Neurology journal, we see how the researchers have developed a simplified diagnosis based on the most specific criteria of the disease. A challenge primarily for research, but also for clinical practice.
-
Press releases - 25.06.2014
Neurons are oversensitive to cellular stress from the outset in Huntington’s disease
Neurons cannot properly defend themselves against Huntington’s disease, right from the onset of the pathology. This has been discovered by a team of Inserm researchers from the Paris-Seine Biology Institute (IBPS) (Inserm/CNRS/Pierre and Marie Curie University) and their American and Australian colleagues. The cause is the failure of an important mechanism involved in cellular longevity. In addition to this result, the present study shows the importance of restoring the ability of the neurons to resist stress in order to delay the manifestations of the disease. This work is leading to a new approach for treating neurodegenerative diseases. The results of this work are published in PLoS Biology.
-
What's on? - 23.06.2014
New outbreak of ebola fever in Africa
According to WHO, between 29 May and 1 June 2014, 37 new cases of Ebola fever and 21 deaths were recorded in Guinea, and 13 new cases (no deaths) were recorded in Liberia. The Jean Mérieux BSL-4 Laboratory is a high-level containment laboratory dedicated to the study of class 4 pathogens. The biological safety level applied is 4, […]